Fieldpoint Private Securities’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$89K Buy
1,333
+635
+91% +$42.4K 0.03% 389
2022
Q1
$57K Buy
+698
New +$57K 0.01% 559